Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
**Objectives:** To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. **Methods:** Adults with at least one medical claim with an aspergillosis...
Saved in:
Main Authors: | Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Break through the mold: Hyper-IgE syndrome as a vehicle for invasive aspergillosis
by: Joseph Nordin, et al.
Published: (2025-01-01) -
Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
by: Yu. A. Kucheryavy, et al.
Published: (2015-12-01) -
TENDENCIES IN FORMING SHEET METAL PARTS USING INCREMENTAL FORMING ADVANCED TECHNOLOGIES
by: CATALINA CIOFU, et al.
Published: (2019-09-01) -
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
by: Callisia N. Clarke, et al.
Published: (2023-12-01) -
Screening of soybean antifungal isoflavones based on targeted metabolomics analysis
by: Nishbah Mughal, et al.
Published: (2025-01-01)